Developed By A Cannabis Expert Who Was Also Diagnosed With ALS in 2012
Discover cannabinoid treatments that have been helping patients facing conditions such as multiple sclerosis, ALS, Parkinson's and many more hard to treat neurological diseases.
Since 2015, Canna Pharms founder, diagnosed with ALS in 2012, has been dedicated to helping ALS patients live longer and restore a higher quality of life.
" In light of the current findings, there is a valid rationale to propose the use of cannabinoid compounds in the pharmacological management of ALS patients. Cannabinoids indeed are able to delay ALS progression and prolong survival." ref; National Library of Medicine
Over the last years, a growing interest was aimed to discovery new innovative and safer therapeutic approaches in the ALS treatment
Studies have found the bioactive compounds of Cannabis show powerful antioxidant, anti-inflammatory and neuroprotective effects in preclinical models of central nervous system disease. Therefore, It's clear Cannabinoid Therapy is a promising treatment for those suffering from ALS and other neurological disorders.
Canna Pharms studies have shown Implementing Cannabinoid Therapy swiftly and aggressively early after symptom onset has the best potential to slow or even halt the progression of most all symptoms ultimately extending a patients lives by over 10yrs. Starting Cannabinoid Therapy immediately after diagnosis has shown to be more effective in slowing progression of the disease.
Cannabinoid Therapy For Over 12 Years
Research suggests that ALS may involve a dysregulation or disruption of the endocannabinoid system. Studies show alterations in endocannabinoid levels and receptor activity within the affected areas of the spinal cord in ALS patients, indicating a potential imbalance of endocannabinoids. In the endocannabinoid system (ECS), a biological system composed of endocannabinoids, which are neurotransmitters that bind to
Cannabinoid Therapy can be used to balance out existing deficiencies in the body’s endocannabinoid system prompting a reduction of excitotoxicity effects as well as reductions in neuroinflammation and oxidative cell injury, all of which are key to the preservation of motor neurons.
For More Information About The EndoCannabinoid System
The Cannabis plant, also known as marijuana, contains over 500 natural compounds and about 70 of these are classified as cannabinoids (Fischedick et al., 2009). The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive principle in Cannabis, as well as the identification of numerous non-psychoactive cannabinoids such as cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC),Δ9-tetrahydrocannabivarin (Δ9-THCV) and cannabidivarin (CBDV), has led to a significant growth in research aimed at understanding the therapeutic effects of these compounds.
Individually isolated cannabinoids in the proper proportions are known to have unique, very powerful individual therapeutic benefits and in combination these create an entourage effect which has the ability to balance your endocannabinoid system ultimately enabling your natural body defense to slow ALS symptom progression and extend overall life expectancy by over 3 times the current averages.
Most People Diagnosed With ALS Die Of Respiratory Failure Within 3-5 Years Of the First Symptom Onset
Being Diagnosed With ALS Is No Longer A Death Sentence
LIVING LONGER WITH ALS IS POSSIBLE
Treatment with Full Spectrum Cannabis Oil with elevated levels of cannabinol (CBN), a non-psychotropic cannabinoid, through its residual affinity to CB1 receptors, is able to delay significantly disease onset in ALS.
Research shows a significant delay in disease progression was found when CB1/CB2 cannabinoid receptor were activated through cannabinoid therapy in ALS mice beginning after onset of motor impairment and tremor.
Overall, the efficacy of cannabinoids in slowing ALS progression, in extending life expectancy and in reducing the overall gravity of the disease creating a higher quality of life is mainly due to activation of CB2 receptors.
When implemented immediately after symptom onset, Cannabinoid Therapy has shown promise in delaying further symptom onset, slowing overall disease progression and significantly prolonging a better quality of life for the ALS patient.
Starting Cannabinoid Therapy at first symptom onset has extended a patient of Canna Pharms life by over 15 years so far from symptom onset.
Starting Cannabinoid Therapy after diagnosis is helping Canna Pharms patients live longer by over 5 years and counting.
Developed By Canna Pharms Founder, Who Is Himself An ALS Patient, To Assist Others Recently Diagnosed With ALS To Live Longer With A Higher Quality Of Life. Custom Formulated Oral Drops, Named MWO Cannabinoid Therapy For ALS, In Combination With Your Existing Treatment Plan Is The Best Solution To Combating ALS And Common Symptoms Of ALS.
Canna Pharms Cannabinoid Therapy Oil for ALS, also called Mike Weaver Oil for ALS, is carefully blended, 30 day supply, oral drops taken 2 times daily for the length of your illness.
Common results of Cannabinoid therapy are a reduction in symptom severity, slowing symptom onset, ease anxiety, less pain and prolonging a higher quality of life.
Mike Weaver Oil for ALS is a carefully blended Full Spectrum Cannabis Oil enhanced with particular cannabinods in the proper proportions to efficiently combat ALS.
Option #1
Purchase your own MWO for ALS online to begin treatment as soon as your MWO Cannabinoid Therapy Oil arrives to your doorstep.
Option #2
Chat with a consultation with a Cannabis Healthcare Professional about incorporating Cannabinoid Therapy into your Treatment Plan.
Option #3
Sign up to become a patient at Canna Pharms Clinic and receive a custom cannabinoid profile specific to your own health and wellness.
It is important to understand that the treatment is not a guaranteed cure for every disease. Patients may be denied for various reasons. The effectiveness of the therapy for a particular disease depends on multiple factors: duration of the illness, age of the patient, the existence of chronic conditions, hereditary predisposition, lifestyle, etc. We’re not here to sell or pressure you into treatment. If you're a suitable candidate, you’ll have the option to proceed with therapy, but the choice is entirely yours. No unrealistic promises. No hidden agendas. Just transparency and support.